raloxifene hydrochloride has been researched along with Cognitive Dysfunction in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Castillo, AM; Couch, FJ; Jack, CR; Kantarci, K; Kara, F; Lesnick, TG; Lohse, CM; Mielke, MM; Olson, JE; Petersen, RC; Ruddy, KJ; Tosakulwong, N | 1 |
| Cobo, J; Creus, M; Cuadras, D; Franco, J; García-Parés, G; Huerta-Ramos, E; Labad, J; Marcó-García, S; Miquel, E; Núñez, C; Reyes, JC; Usall, J | 1 |
| Barbero, JD; Bioque, M; Cobo, J; García-Rizo, C; González-Rodríguez, A; Huerta-Ramos, E; Labad, J; Monreal, JA; Soria, V; Tost, M; Usall, J | 1 |
1 review(s) available for raloxifene hydrochloride and Cognitive Dysfunction
| Article | Year |
|---|---|
Targeting hypothalamic-pituitary-adrenal axis hormones and sex steroids for improving cognition in major mood disorders and schizophrenia: a systematic review and narrative synthesis.
Topics: Affective Disorders, Psychotic; Bipolar Disorder; Cognition Disorders; Cognitive Dysfunction; Depressive Disorder, Major; Female; Gonadal Steroid Hormones; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Male; Mifepristone; Mood Disorders; Pituitary-Adrenal System; Pregnenolone; Raloxifene Hydrochloride; Schizophrenia | 2018 |
1 trial(s) available for raloxifene hydrochloride and Cognitive Dysfunction
| Article | Year |
|---|---|
Effects of raloxifene on cognition in postmenopausal women with schizophrenia: a 24-week double-blind, randomized, parallel, placebo-controlled trial.
Topics: Aged; Antipsychotic Agents; Attention; Cognitive Dysfunction; Double-Blind Method; Drug Therapy, Combination; Executive Function; Female; Humans; Memory Disorders; Middle Aged; Postmenopause; Raloxifene Hydrochloride; Schizophrenia; Selective Estrogen Receptor Modulators; Treatment Outcome | 2020 |
1 other study(ies) available for raloxifene hydrochloride and Cognitive Dysfunction
| Article | Year |
|---|---|
Association of raloxifene and tamoxifen therapy with cognitive performance, odds of mild cognitive impairment, and brain MRI markers of neurodegeneration.
Topics: Aged; Brain; Breast Neoplasms; Cognition; Cognitive Dysfunction; Cross-Sectional Studies; Female; Humans; Middle Aged; Raloxifene Hydrochloride; Receptors, Estrogen; Selective Estrogen Receptor Modulators; Tamoxifen | 2023 |